ERBB2 and pancreatic neoplasm: A variety of tumors has been positively analyzed for ErbB2 overexpression or gene amplification: non-small-cell lung cancer, ovarian cancer, bladder cancer, pancreatic cancer, and salivary duct carcinoma [88].